Senator to Investigate FDA Rejections of Rare Disease Drugs

(MedPage Today) — Sen. Ron Johnson (R-Wisc.) said Tuesday he would begin an investigation into the FDA’s handling of approval applications for biologic therapies to treat Duchenne muscular dystrophy (DMD) and other rare life-threatening disorders…

Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/120247

Author :

Publish date : 2026-03-10 21:43:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Senator to Investigate FDA Rejections of Rare Disease Drugs

FDA Reverses Stance on Leucovorin for Autism

Tale of Two Drugs: Wegovy Linked to Higher Risk of Blinding Eye Stroke vs Ozempic

Related Posts

Can Gabapentin Improve Brain Injury Outcomes?

‘I paid for a private hysterectomy’

Olympic Track and Field Star Allyson Felix Talks Rest and Recovery

Quiz Time: Is Paxlovid Still Reducing COVID Hospitalizations?

Continued Insulin Pump Use in the Hospital Improves Outcomes

Controlling Hypertension After Intracerebral Hemorrhage; Treating Acute Sinusitis

Can Gabapentin Improve Brain Injury Outcomes?

‘I paid for a private hysterectomy’

Olympic Track and Field Star Allyson Felix Talks Rest and Recovery

Quiz Time: Is Paxlovid Still Reducing COVID Hospitalizations?

Continued Insulin Pump Use in the Hospital Improves Outcomes

Controlling Hypertension After Intracerebral Hemorrhage; Treating Acute Sinusitis

Symptom-Based Dosing Gets Infants With Opioid Withdrawal Out of the Hospital Faster

Vaccines, Budget Cuts, Affordability: Takeaways From RFK Jr.’s Gauntlet of Hearings

Categories

Archives